MRSN

Mersana Therapeutics, Inc. MRSN

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MRSN KZR ALGS FGEN OKUR TPST XFOR BRNS INMB BCAB
6M 216.28 % 40.27 % 41.46 % 49.57 % 27.00 % -53.98 % 34.83 % -12.14 % -71.32 % 87.69 %
YTD -17.31 % -3.50 % -73.18 % -35.00 % -64.67 % -72.04 % -84.04 % -40.40 % -62.88 % 22.70 %
1Y -33.47 % -2.76 % -72.15 % -2.71 % -62.61 % -66.67 % -80.24 % -27.55 % -58.60 % -36.69 %
3Y -79.66 % -99.04 % -57.70 % -97.58 % -87.19 % -81.82 % -82.61 % -65.79 % -75.30 % -90.72 %
5Y -95.68 % -98.79 % -98.40 % -99.14 % -97.99 % -90.76 % -98.13 % -94.76 % -82.95 % -97.66 %
10Y -91.73 % -99.64 % -97.12 % -98.85 % -97.99 % -99.86 % -99.86 % -94.76 % -77.10 % -97.57 %
From the beginning -91.73 % -99.64 % -97.12 % -98.44 % -97.99 % -99.82 % -99.86 % -94.76 % -77.10 % -97.57 %

Dividend